Idiopathic Constipation
📧 Sign up to get email alerts when something new happens for Idiopathic Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Maralixibat in Patients With Cystic Fibrosis and Constipation [Phase 2, Phase 3]
This clinical trial update indicates that maralixibat is being studied in patients with cystic fibrosis and constipation, with Phase 2 and P…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: MOWOOT Device Treatment for Adults With Chronic Constipation [NA]
The clinical trial update reports completion of a study evaluating the MOWOOT device for adults with chronic constipation and related condit…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults [Phase 3]
This Phase 3 clinical trial update shows recruitment ongoing to assess the safety and efficacy of tenapanor for treating chronic idiopathic …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: "Efficacy and Safety of Linaclotide in Chronic Constipation" [Phase 4]
Phase 4 trial evaluating the efficacy and safety of linaclotide for chronic constipation is not yet recruiting. The study sponsor is Md Mehe…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Soluble and Osmotic Fibre (SOLOS) Diet for Constipation
The SOLOS Diet trial investigates soluble and osmotic fiber as a treatment for constipation. The study status is NOT_YET_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-01-29FDA Approved: PRUCALOPRIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for PRUCALOPRIDE submitted by Viona Pharmaceuticals Inc.
-
FDA approval · 2026-01-16FDA Approved: PRUCALOPRIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA's original ANDA for prucalopride (generic) for the treatment of chronic idiopathic constipation.
-
FDA label_change · 2025-11-04FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA supplemental application for Linzess (linaclotide) submitted by Allergan to modify labeling.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation [Phase 3]
Phase 3 pediatric trial comparing linaclotide to placebo in children aged 2 to 5 with functional constipation, focusing on adverse events an…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Post-Marketing Study of Prucalopride Safety In Pregnancy
This clinical trial update outlines a post-marketing study to evaluate the safety of prucalopride in pregnancy for patients with chronic idi…
-
FDA approval · 2025-08-07FDA Approved: PRUCALOPRIDE — Original Application (Viona Pharmaceuticals Inc)
FDA approved prucalopride via an original application filed by Viona Pharmaceuticals Inc for use in chronic constipation.
-
FDA approval · 2025-07-10FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., indicating an update to …
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for prucalopride. It is indicated for the treatment of chronic idiopathic constipatio…
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for prucalopride, enabling a generic version for chronic idiopathic constipation.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for prucalopride (generic) for chronic idiopathic constipation.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (SpecGx LLC)
FDA approved the original application for prucalopride submitted by SpecGx LLC.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original abbreviated new drug application (ANDA) for prucalopride by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (SKG Pharma Inc.)
FDA approved a generic version of prucalopride (SKG Pharma Inc.) through an Original Application/ANDA submission (ANDA 218812). This generic…
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Sandoz Inc.)
FDA approved the original application for a generic version of prucalopride (PRUCALOPRIDE) by Sandoz Inc., for the treatment of chronic idio…
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approved Hikma Pharmaceuticals USA Inc's prucalopride original application.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE SUCCINATE — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics, LLC's original application for prucalopride succinate as a generic version of prucalopride for adults wi…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation
ProgenaBiome's pilot clinical trial investigating the role of gut flora in chronic constipation has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: A Study of Prucalopride in Breastfeeding Women With Constipation
A clinical trial update shows that a study of prucalopride in breastfeeding women with chronic idiopathic constipation is currently recruiti…
-
FDA approval · 2025-01-02FDA Approved: LUBIPROSTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original generic application for lubiprostone to treat chronic idiopathic constipation, opioid-induced …
-
FDA approval · 2024-12-26FDA Approved: PRUCALOPRIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original Abbreviated New Drug Application for prucalopride, confirming a generic version of the prokinetic…